Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2006
12/21/2006US20060287227 Gonadal function improving agents
12/21/2006US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying
12/21/2006US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006US20060286107 Parathyroid hormone antibodies and related methods
12/21/2006CA2610222A1 Steroids having a mixed androgenic and progestagenic profile
12/20/2006EP1733734A2 Placental alkaline phosphatase to control diabetes
12/20/2006EP1733732A1 Insulin resistance improving agent
12/20/2006EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders
12/20/2006EP1732921A1 Thioamide derivatives as progesterone receptor modulators
12/20/2006EP1732890A1 Crystalline polymorph of a bazedoxifene acetate
12/20/2006EP1732889A1 Crystalline polymorph of bazedoxifene acetate
12/20/2006EP1732888A1 Bazedoxifene ascorbate as selective estrogen receptor modulator
12/20/2006EP1506200B1 Diazabicyclic biaryl derivatives
12/20/2006EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors
12/20/2006EP1372665B1 Hormone replacement therapy method and its administration form
12/20/2006EP0858336B1 Method and pharmaceutical composition for regulating lipid concentration
12/20/2006CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/20/2006CN1879629A Estrogen replacement therapy
12/20/2006CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006CN1290813C Process for the preparation of non-steroidal glucocorticoid receptor modulators
12/20/2006CN1290518C Extracting method of propolis effective component and its use
12/20/2006CN1290507C Steroid hormone products and preparing method thereof
12/19/2006US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/19/2006US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/14/2006WO2006132442A1 Vitamin d-like compound
12/14/2006WO2006132295A1 Regulator of aldosterone receptor
12/14/2006WO2006131799A2 Compositions based on phyto-oestrogen extracts for the treatment of menopausal and pre-menstrual syndrome, benign prostate hypertrophy, and polycystic ovary syndrome
12/14/2006WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006US20060281685 biodrug as antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/14/2006US20060281679 Human FGF-23 gene and gene expression products
12/14/2006US20060280719 An addition polymer from an unsaturated monomer containing a phosphonate group and a phosphinate group separated from eachother by an optionally fluorinated methylene group; treatment of hyperphosphotemia, chronic renal failure, hyperparathyroidism, uremic bone disease, or osteoporosis
12/13/2006EP1731168A1 Antibody drug
12/13/2006EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/13/2006EP1730268A2 Differentiation of stem cells to endoderm and pancreatic lineage
12/13/2006EP1730155A1 Thienopyrroles as antagonists of gnrh
12/13/2006EP1730127A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
12/13/2006EP1729776A1 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
12/13/2006EP1729756A2 Novel pharmaceutical compositions
12/13/2006EP1328252B1 Transdermal pharmaceutical delivery composition
12/13/2006EP1143989B1 Exendins for glucagon suppression
12/13/2006CN1878548A Combinations of at1-antagonists, amiloride or triamterine, and a diuretic.
12/13/2006CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof
12/13/2006CN1875994A Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/13/2006CN1875977A Use of tanshinone compound in preparation of medicine for treating Grave's disease
12/13/2006CN1289143C Method for reducing decreasing blood-glucose and delaying weight increase of diabetic
12/13/2006CN1289082C Medicine composition for treating diabetes
12/13/2006CN1289073C Hair growth stimulant
12/13/2006CN1289064C Drug delivery system
12/12/2006US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006US7148213 Steroids with fluoroalkyl groups as antigestation steroids used in gynecological treatment
12/12/2006US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/12/2006CA2154161C Therapeutic uses and delivery systems of dehydroepiandrosterone
12/07/2006WO2006129995A1 Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent
12/07/2006WO2006129826A1 Novel piperidine derivative
12/07/2006WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006WO2006129076A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone
12/07/2006WO2006128852A2 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006WO2006128851A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006WO2006128337A1 A pharmaceutical composition for prevention and treatment of menopausal syndrome and method of preparing the same
12/07/2006US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
12/07/2006US20060276443 21-substituted progesterone derivatives as new antiprogestational agents
12/07/2006US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006DE60118395T2 Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen Pharmaceutical compositions of active ingredients with controlled release for the parenteral administration of hydrophilic
12/07/2006CA2609930A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006CA2609818A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone
12/07/2006CA2609660A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006CA2609388A1 Novel piperidine derivative
12/06/2006EP1727555A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity
12/06/2006EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof
12/06/2006EP1446128B1 Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
12/06/2006EP1091738B1 BICYCLIC sPLA 2 INHIBITORS
12/06/2006CN1874765A Accelerator for initial insulin secretion
12/06/2006CN1872997A New technique for culturing stem cells (carrying therapy gene) of human's xenogenic stromata in large-scale
12/06/2006CN1872344A Gene therapy method of stem cell (carrying therapy gene) of human xenogenic stroma
12/06/2006CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/05/2006USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006US7145015 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents
12/05/2006US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
12/05/2006US7144900 Pharmaceutical composition
12/05/2006US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
12/05/2006US7144707 Determination of risk and treatment of complications of prematurity
12/05/2006US7144586 Compositions for preventing hormone induced adverse effects
12/05/2006CA2531834C Pharmaceutical compositions comprising pioglitazone and an insulin secretion enhancer
11/2006
11/30/2006WO2006127941A2 Amorphous cinacalcet hydrochloride and preparation thereof
11/30/2006WO2006127932A2 Purification of cinacalcet
11/30/2006WO2006127057A1 Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction
11/30/2006WO2006126718A1 Pyrazolopyrimidine derivative
11/30/2006WO2006126673A1 Combined drug for treating diabetes
11/30/2006WO2006126514A1 Arylacetate derivative having isoxazole skeleton
11/30/2006WO2006125800A1 17β-HSD1 AND STS INHIBITORS
11/30/2006WO2006125642A1 Methods and apparatus for transdermal or transmucosal application of testosterone
11/30/2006WO2006125285A1 Insulin sensitization to slow down pubertal tempo and to augment pubertal growth
11/30/2006US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006US20060270681 Pyridazine derivatives
11/30/2006US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006US20060270660 Processes for preparing substituted pyrimidines
11/30/2006US20060270649 Azetidine derivatives, their preparation and medicaments containing them